Long-term Results of Robotic Modified Belsey (Gastroesophageal Valvuloplasty) Fundoplication.


Journal

Surgical technology international
ISSN: 1090-3941
Titre abrégé: Surg Technol Int
Pays: United States
ID NLM: 9604509

Informations de publication

Date de publication:
15 May 2019
Historique:
pubmed: 1 12 2018
medline: 4 9 2019
entrez: 1 12 2018
Statut: ppublish

Résumé

Nissen fundoplication is associated with poor long-term durability, as well as dysphasia and gas bloat. We report here the long-term results of modified Belsey fundoplication (Gastroesophageal Valvuloplasty; GEV) performed laparoscopically using a surgical robot. Patients who underwent robotic GEV were reviewed retrospectively. Operations were performed by laparoscopy and included robotic dissection of the esophageal hiatus, primary closure of the hiatus, followed by intussusception of a 4 cm segment of the esophagus into the stomach for 270°, and suspension of the fundoplication on the hiatal closure. The results were assessed by postoperative endoscopy, contrast esophagography, a Subjective Symptom Questionnaire (SSQ), and objective Visick grading. There were 291 patients (156 male, 135 female, mean age 51±14 years). Indications were intractability (73%) and pulmonary symptoms (27%). Mean operative time was 130 minutes ± 52 minutes. Minor complications were seen in 21%. There was no mortality. Mean hospitalization was 2.8 days ± 1.7 days. Mean follow-up was 85 months ± 7 months. During this period, the mean SSQ score decreased from 8.3 ± 0.6 to 0.7± 0.2 (P < 0.05). There was no long-term dysphasia or gas bloat. Ninety-five percent of patients were Visick I and 5% were Visick II. Hiatal hernia recurred in 7 patients (2%). Robotic laparoscopic modified Belsey fundoplication (GEV) is associated with excellent long-term durability, reflux control, and low rates of dysphasia and gas bloat. This procedure may represent an alternative to medical antireflux therapy and other surgical antireflux procedures such as Nissen fundoplication.

Identifiants

pubmed: 30500978
pii: sti34/1091

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

121-127

Auteurs

Farid Gharagozloo (F)

Director of Cardiothoracic Surgery, Advanced Thoracic Surgery Program, Global Robotics Institute, Florida Hospital Celebration Heath, University of Central Florida, Celebration, FL.

Basher Atiquzzaman (B)

Advanced Thoracic Surgery Program, Global Robotics Institute, Florida Hospital Celebration Heath, University of Central Florida, Celebration, FL.

Barbara Tempesta (B)

Advanced Thoracic Surgery Program, Global Robotics Institute, Florida Hospital Celebration Heath, University of Central Florida, Celebration, FL.

R C Tolboom (RC)

Meanders Medical Center, Amersfoort, The Netherlands.

Mark Meyer (M)

University of Arizona Medical Center, Tucson, AZ.

Stephan Gruessner (S)

University of Arizona Medical Center, Tucson, AZ.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH